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Abstract: The purpose of this consensus paper is to review electrophysiological abnormalities and to pro-
vide a guideline of neurophysiological assessments in cerebellar ataxias. All authors agree that standard
electrophysiological methods should be systematically applied in all cases of ataxia to reveal accompany-
ing peripheral neuropathy, the involvement of the dorsal columns, pyramidal tracts and the brainstem.
Electroencephalography should also be considered, although findings are frequently non-specific. Elec-
trophysiology helps define the neuronal systems affected by the disease in an individual patient and to
understand the phenotypes of the different types of ataxia on a more general level. As yet, there is
no established electrophysiological measure which is sensitive and specific of cerebellar dysfunction in
ataxias. The authors agree that cerebellar brain inhibition (CBI), which is based on a paired-pulse tran-
scranial magnetic stimulation (TMS) paradigm assessing cerebellar-cortical connectivity, is likely a useful
measure of cerebellar function. Although its role in the investigation and diagnoses of different types
of ataxias is unclear, it will be of interest to study its utility in this type of conditions. The authors
agree that detailed clinical examination reveals core features of ataxia (i.e., dysarthria, truncal, gait and
limb ataxia, oculomotor dysfunction) and is sufficient for formulating a differential diagnosis. Clinical
assessment of oculomotor function, especially saccades and the vestibulo-ocular reflex (VOR) which are
most easily examined both at the bedside and with quantitative testing techniques, is of particular help
for differential diagnosis in many cases. Pure clinical measures, however, are not sensitive enough to
reveal minute fluctuations or early treatment response as most relevant for pre-clinical stages of disease
which might be amenable to study in future intervention trials. The authors agree that quantitative
measures of ataxia are desirable as biomarkers. Methods are discussed that allow quantification of ataxia
in laboratory as well as in clinical and real-life settings, for instance at the patients’ home. Future studies
are needed to demonstrate their usefulness as biomarkers in pharmaceutical or rehabilitation trials.
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Abstract: The purpose of this consensus paper is to review electrophysiological abnormalities
and to provide a guideline of neurophysiological assessments in cerebellar ataxias. All
authors agree that standard electrophysiological methods should be systematically
applied in all cases of ataxia to reveal accompanying peripheral neuropathy, the
involvement of the dorsal columns and pyramidal tracts and the brainstem.
Electroencephalography should also be considered although findings are frequently
unspecific. Electrophysiology helps define the neuronal systems affected by the
disease in an individual patient and to understand the phenotypes of the different types
of ataxia on a more general level. As yet, there is no established electrophysiological
measure which is sensitive and specific of cerebellar dysfunction in ataxias. The
authors agree that cerebellar brain inhibition (CBI), which is based on a paired-pulse
transcranial magnetic stimulation (TMS) paradigm assessing cerebellar-cortical
connectivity, is likely a useful measure of cerebellar function. Although its role in the
investigation and diagnoses of different type of ataxias is unclear, it will be of interest to
study its utility in this type of conditions. The authors agree that detailed clinical
examination reveals core features of ataxia (i.e. dysarthria, truncal, gait and limb
ataxia, oculomotor dysfunction) and is sufficient for formulating a differential diagnosis.
Clinical assessment of oculomotor function, especially saccades and the vestibulo-
ocular reflex (VOR) which are most easily examined both at the bedside and with
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quantitative testing techniques, is of particular help for differential diagnosis in many
cases. Pure clinical measures, however, are not sensitive enough to reveal minute
fluctuations or early treatment response as most relevant for pre-clinical stages of
disease which might be amenable to study in future intervention trials. The authors
agree that quantitative measures of ataxia are desirable as biomarkers. Methods are
discussed that allow quantification of ataxia in laboratory as well as in clinical and real-
life settings, for instance at the patients' home. Future studies are needed to
demonstrate their usefulness as biomarkers in pharmaceutical or rehabilitation trials.
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Dear Prof. Molinari 
 
Thank you very much for giving us the opportunity for a resubmission of our manuscript as well as for 
sending us the constructive comment of the reviewer. We have addressed all comments of the 
reviewer and we hope that we were able in a satisfying way to address all concerns, so that the 
manuscript will now be suitable for publication. 





Reviewer #2: CERE-D-17-00096: Consensus paper: Neurophysiological 
assessments of ataxias in daily practice 
 
This comprehensive review article aims at exploring the contribution of 
the neurophysiological techniques in the assessment of patients with 
ataxia. The authors discuss the possible usefulness of different methods 
in both the phenotype definition and follow-up. 
 
The authors review a bulk of literature covering different aspects of the 
diseases characterized by ataxic symptoms. However, it is somehow 
difficult to retain clear take-home messages among a so large amount of 
information. In particular, there is often confusion between clinical and 
neurophysiological assessment of the patient, especially concerning gait, 
posture, and ocular movement analysis. 
 
Authors’ response: The reviewer raises an important issue which has been intensively discussed 
among the authors during initial preparation of the manuscript. There is consensus among the 
authors that it is important to report the key clinical motor findings in the different domains. 
This is because the clinical findings are closely related to any quantitative measure and, in a 
clinical setting, are sufficient to diagnose ataxia. They are also the basis to understand any 
quantitative measures. Quantitative neurophysiological measures, however, are discussed in 




1)        The whole chapter on the EEG is focused on the clinical 
features of the epileptic syndromes associated to ataxias rather than 
on what the EEG can add in the phenotypical characterization of ataxic 
patients. The clinical introduction to episodic ataxias should be moved 
to the Introduction. 
Author’s response: The chapter on EEG has been carefully edited. We tried to follow the 
advice of the reviewer as much as possible. However, data on EEG characteristics is 
frequently not reported in detail in ataxias with accompanying epilepsy in the literature. The 
clinical introduction to episodic ataxias was shortened.  
 
 
2)        The speech assessment is based only on clinical examination. 
What is the contribution of clinical neurophysiology? 
Authors' Response to Reviewers' Comments Click here to download Authors' Response to Reviewers'
Comments Consensus_Reviewer_response_15-2-
Author’s response: As suggested by the reviewer, a paragraph has been added describing the 
contributions of quantitative measures in speech assessment.     
 
3)        Also in the gait assessment chapter, there is an initial 
overview of the clinical assessment which seems to be out of the 
purpose of the present review. 
Author’s response: In the revision of the manuscript, we shortened the review of the clinical 
assessment and put more emphasis on quantitative methods including EMG.  
 
 
4)        In the chapter about the posture assessment, the authors 
should be more focused on the techniques for the quantitative analysis. 
On the contrary, they deal mostly with the clinical assessment of the 
patient. 
 
Author’s response: In response to the reviewers’ suggestions, we described in more detail the 
quantitative methods including force plates to quantify hypermetric center of foot pressure, 
surface electromyography to measure intramuscular temporal coordination, and motion 
capture to characterize control of body center of mass by whole body kinematics. 
 
5)        In both chapters about ocular movement and vestibulo-ocular 
reflex assessment, the introduction about the physiological mechanisms 
is definitely too long and, in the case of ocular movement, scarcely 
addressed to the role of cerebellum. In both chapters a larger 
attention should be posed on the description of the neurophysiological 
methods of assessment. 
 
Author’s response: In agreement with the reviewer’s suggestions, we re-wrote these two 
chapters considerably.  
- We shortened the introduction of both sections substantially.  
- We described the functional role of the cerebellum in detail on saccades, as that is our 
focus in this chapter and most helpful, both at the bedside and with quantitative 
measures, as an aide to cerebellar diagnosis or treatment. We also have considerable 
discussion of specific parts of the cerebellum and vestibular function, the other key 
type of eye movement emphasized here, as well as detailed anatomical physiological 
correlations in Table. 
- In order to pose a larger attention on the description of the neurophysiological 
methods we enlarged the section   “Quantitative methodology for evaluating eye 
movements in patients with suspected cerebellar dysfunction.”  We added a few 
sentences in the saccade section at the end of each saccade descriptor (velocity / 
range etc) commenting on the core requirement of a neurophysiologic measure (i.e. 
high frame rate).  
- Additionally, we added several sentences specifying the pros / cons of 
electrooculography, magnetic scleral coil, and video measurements.  
 
In conclusion, in spite of the title and what the authors maintain in 
the Introduction, that is to review the contribution of the clinical 
neurophysiology to the assessment of ataxic patients, their review, 
especially in the second part, includes so many clinical aspects that 
risk to confound the reader. From this point of view, there is a clear 
contrast between the initial part, which is clearly focused on the 
neurophysiological techniques (nerve conduction study, SEPs, VEPs, 
BAEPs, EEG, MEPs), and the last one dealing with particular clinical 
aspects (gait, ocular movements, posture). This makes the review 
scarcely homogenous and somehow difficult to read. 
 
Authors’ response: The reviewer is correct. There are two parts of the consensus paper. A part 
which addresses electrophysiological measures, and a part which addresses clinical and 
quantitative measures of the key motor symptoms of ataxia. This has been stated more clearly 
in the revised introduction. The authors believe that both parts are important although they 
necessarily use very different approaches. Electrophysiological measures allow to assess 
extracerebellar involvement in ataxias. With the possible exception of TMS-CBI, the key motor 
findings of ataxia, however, cannot be assessed. Because quantitative measures of ataxia are 
closely related to the clinical symptoms, the authors believe that a summary of the clinical 
findings are helpful to the reader, in particular assessing speech and oculomotor signs. In the 
revised version of the review, however, the current developments of quantitative measures of 
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The purpose of this consensus paper is to review electrophysiological abnormalities and to 
provide a guideline of neurophysiological assessments in cerebellar ataxias. All authors agree 
that standard electrophysiological methods should be systematically applied in all cases of 
ataxia to reveal accompanying peripheral neuropathy, the involvement of the dorsal columns 
and pyramidal tracts and the brainstem. Electroencephalography should also be considered 
although findings are frequently unspecific. Electrophysiology helps define the neuronal 
systems affected by the disease in an individual patient and to understand the phenotypes of the 
different types of ataxia on a more general level. As yet, there is no established 
electrophysiological measure which is sensitive and specific of cerebellar dysfunction in 
ataxias. The authors agree that cerebellar brain inhibition (CBI), which is based on a paired-
pulse transcranial magnetic stimulation (TMS) paradigm assessing cerebellar-cortical 
connectivity, is likely a useful measure of cerebellar function. Although its role in the 
investigation and diagnoses of different type of ataxias is unclear, it will be of interest to study 
its utility in this type of conditions. The authors agree that detailed clinical examination reveals 
core features of ataxia (i.e. dysarthria, truncal, gait and limb ataxia, oculomotor dysfunction) 
and is sufficient for formulating a differential diagnosis. Clinical assessment of oculomotor 
function, especially saccades and the vestibulo-ocular reflex (VOR) which are most easily 
examined both at the bedside and with quantitative testing techniques, is of particular help for 
differential diagnosis in many cases. Pure clinical measures, however, are not sensitive enough 
to reveal minute fluctuations or early treatment response as most relevant for pre-clinical stages 
of disease which might be amenable to study in future intervention trials. The authors agree that 
quantitative measures of ataxia are desirable as biomarkers. Methods are discussed that allow 
quantification of ataxia in laboratory as well as in clinical and real-life settings, for instance at 
the patients’ home. Future studies are needed to demonstrate their usefulness as biomarkers in 





































































A large number of heterogeneous disorders are encapsulated by the term “ataxias.” In daily 
praxis, it is often difficult to isolate a specific subtype of ataxia only from clinical examination. 
The aim of this consensus paper is to propose guidelines for neurophysiological assessments 
for the diagnostic work-up of ataxias. We also address the question whether neurophysiological 
assessments may be useful biomarkers to monitor disease course and the effects of emerging 
treatments. 
Broadly, primary ataxias are distinguished from secondary or acquired ataxias. Primary ataxias 
are subdivided into sporadic and hereditary ataxias [1]. Hereditary ataxias include autosomal 
recessive cerebellar ataxias (ARCA), autosomal dominant cerebellar ataxias (ADCA, 
spinocerebellar ataxias or SCAs), episodic ataxias (EA), X-linked ataxias, and mitochondrial 
ataxias. Currently, there are more than 40 types of SCAs described, with SCA3 the most 
common form worldwide. SCA types 1, 2, 6, and 7 are the next most common types whereas 
the other SCA genotypes represent a group of rare diseases, some described in single families. 
Friedreich’s ataxia (FRDA) is autosomal recessively inherited and is the most frequent form of 
hereditary ataxia in the western world. The number of recessive ataxias with known disease 
genes is currently fast growing [2]. Additionally, congenital ataxias can be caused by cerebellar 
malformations or pontocerebellar hypoplasia, most commonly related to genetic causes. 
Finally, there is overlap between ataxias and complex types of hereditary spastic paraplegias 
(HSP) [3]. Sporadic degenerative ataxias include multiple system atrophy (MSA – cerebellar 
type), and sporadic adult onset ataxia of unknown etiology (SAOA) [4]. Secondary or acquired 
ataxias are due to exogenous or endogenous generally non-genetic causes, including toxic, 
paraneoplastic, immune-mediated, nutritional, and infectious [1].  
Common clinical features in patients with ataxias are imbalance, incoordination, and often 
impaired speech. Degeneration involves the cerebellar parenchyma and/or cerebellar afferent 




































































system (the involvement of which can further refine diagnostic considerations). Accompanying 
derangement of the vestibular system, pyramidal tracts, brainstem nuclei, and basal ganglia, 
among others, are frequently present in ataxias. Furthermore, large- and small-fiber 
polyneuropathy are very common. In fact, extracerebellar involvement is the rule in ataxias, 
and pure cerebellar disorders are the exception. As balance requires both cerebellar and 
extracerebellar structures, extracerebellar involvement may be the primary driver of disordered 
balance and incoordination, e.g. in FRDA. Cerebellar nuclei and spinocerebellar tracts are 
involved in FRDA. FRDA, however, is a predominantly sensory ataxia due to early and 
pronounced affection of the dorsal root ganglia, dorsal columns and sensory polyneuropathy 
[5]. In addition, most patients with FRDA develop significant pyramidal tract symptoms further 
impairing truncal stability. 
The sine qua non in the diagnostic work-up of ataxias is the demonstration of cerebellar 
dysfunction, which may be challenging at disease onset given the insidious and slowly 
progressive nature of many ataxias. Next, consider whether the patient has significant 
extracerebellar involvement; this would sharpen phenotypic or syndromic considerations, 
winnowing a broad differential, and focus further genetic testing. Ataxia panels and exome 
analyses are increasingly used to diagnose hereditary ataxias [6]. They do have their limitations 
and pitfalls, and to analyze a limited number of target genes increases the sensitivity of genetic 
testing. In addition, there is growing demand for sensitive biomarkers to monitor the course of 
the disease and effects of treatment in upcoming interventional trials.  
Neurophysiological assessments are often equated with electrophysiological assessments, that 
is, nerve conduction studies, electromyography (EMG), sensory and motor evoked potentials 
(SEP, MEP) and electroencephalography (EEG). These are routine procedures and are widely 
available in neurology departments. Electrophysiological methods are useful to detect 
extracerebellar involvement including: polyneuropathy, dorsal columns, pyramidal tracts, 




































































demonstration or quantification of cerebellar involvement, the core problem in most types of 
ataxias. The assessment of cerebellar brain inhibition (CBI) using transcranial magnetic 
stimulation (TMS) is the only exception. CBI, however, has not been systematically applied in 
ataxias, and is not part of the diagnostic routine.  
The consensus paper has two parts. In the first part, we will discuss findings of 
electrophysiological studies in ataxias. In the second part, we will discuss the clinical 
assessment of the core symptoms of cerebellar disease and make reference to possible 
quantitative measures. For instance, imbalance in gait and stance is often the presenting but 
non-specific complaint of patients referred to a neurologist for an evaluation for a cerebellar 
ataxia syndrome. Bedside teaching of the neurological examination traditionally focuses on 
gross deficits such as tremor, muscle weakness, and impaired sensation. Abnormalities of eye 
movements may be less apparent but are often the key to localization and etiology. Another 
complicating feature is that normal balance requires efficient operation of many different 
cortical, subcortical and infratentorial systems. These include: foundational structural elements 
(skeletal system integrity and axial weight-bearing muscle power), primary sensory (afferent 
sensory proprioception and semicircular canal- and otolith-mediated vestibular responses), 
higher-order/multimodal cerebral integrative and associative circuits that mediate volition, 
motivation and agency, and finally corrective structures (basal ganglia and cerebellum) that 
gate activity and ensure that movements are accurate [7]. In contrast to the assessment of gait 
and balance impairments, the assessment of eye movement impairments can contribute more to 
differential diagnosis, showing distinct impairment for different types of ataxia [8]. While 
quantification is always the goal and many neurology departments are equipped with clinical 
electrooculography set-ups, simple inspection easily reveals most eye movement disorders at 
the bedside.  
Quantitative assessment of ataxia of stance and gait, as well as limb ataxia and dysarthria is 




































































kinetographs, and high resolution microphones for acoustic analysis of speech. In addition, in 
the differential diagnosis of ataxias, the gain of quantitative assessment is often limited 
compared to the clinical evaluation, and, as yet, most neurology departments do not provide the 
necessary equipment except clinical electrooculography set-ups. This is different in the 
situation where treatment effects, e.g. in a drug trial need to be quantified. Treatment effects in 
a short time interval are likely small and will not be picked up by clinical examination.  
We will start with reviews of known findings in the literature about electrophysiological studies 
in ataxias (see Tables 1 and 2). Regarding the core symptoms, speech, stance, gait and eye 
movement assessment, we will begin with categorizing common chief complaints, then their 
examination correlates and ultimately their anatomic and functional localization (see Tables 3-
6). We will incorporate discussion of quantitative methodology within each section to 
emphasize the complementary roles of clinical and neurophysiological assessment. The role of 
neurophysiological assessments in the differential diagnosis of ataxias and increasingly difficult 
classification of its different types will be discussed. Furthermore, we aimed to evaluate the 
prospects as potential biomarkers for some of the cerebellar ataxias. 
 
Nerve conduction studies and electromyography (EMG) 
L. Schöls, Tübingen, Germany 
Involvement of peripheral nerves is frequent in hereditary ataxias. Some genotypes present with 
predominant sensory neuropathy whereas others develop a sensory-motor type but not pure 
motor neuropathies (Table 1) [9-14]. Some subtypes of ataxia like ataxia with coenzyme Q10 
deficiency and ataxia with SYNE1 mutations typically do not develop peripheral neuropathy, 
and respective phenotyping may help in the clinical differentiation of the genetic subtypes. In 
Friedreich’s ataxia (FRDA), nerve conduction studies reveal severe sensory neuropathy of 
axonal type in almost all patients with genetically proven disease while motor nerve conduction 
studies are usually normal [15]. Similar findings as in FRDA are obtained in nerve conduction 




































































dysarthria and ophthalmoplegia (SANDO) [16]. Also ataxia with primary vitamin E deficiency 
(AVED) presents with pure sensory axonal neuropathy but the reduction in sensory nerve action 
potentials (SNAP) tends to be less severe than in FRDA [17]. 
In contrast to this group of ataxias with pure sensory neuropathies that result from primarily 
mitochondrial defects, there is a group that is characterized by the combined affection of 
sensory and motor fibres and is caused by impaired DNA repair. This group includes ataxia 
telangiectasia (AT), Ataxia with oculomotor apraxia type 1 (AOA1) and Ataxia with 
oculomotor apraxia type 2 (AOA2) each of them going along with distally pronounced sensory-
motor neuropathy [14, 18, 19]. Autosomal recessive spastic ataxia of Charlevoix Saguenay 
(ARSACS) also presents with sensory-motor neuropathy but in contrast to the DNA repair 
disorders mentioned before it shows more dysmyelinating features [20]. 
In the dominantly inherited spinocerebellar ataxias (SCA) nerve conduction studies reveal 
peripheral nerve affection in most patients with SCA1, SCA2, SCA3 and SCA7 and less 
frequently also SCA6 [11, 13, 21, 22]. Peripheral neuropathy presents in genotype-specific 
patterns. In SCA3 peripheral neuropathy affects sensory and motor nerves. SCA3 neuropathy 
occurs in some patients with subclinical dysfunction that is only detected by nerve conduction 
studies but may in other patients constitute the major manifestation of disease. In a 
multifactorial regression analysis, age but not CAG repeat length nor disease duration was 
identified as the major factor that correlates with both compound muscle action potentials in 
motor nerves as well as sensory nerve action potential in sensory nerves (SNAP) [23]. 
Accordingly, peripheral neuropathy is the major manifestation in patients with relatively short 
expansions and late onset of disease [24]. In SCA2 neuropathy predominantly affects sensory 
nerves with a decrease in sural SNAP with longer disease duration and more severe disease 
[25]. In SCA1 sensory and motor nerves are affected but differ from the other genotypes by a 




































































Peripheral nerve affection has been proven even in presymptomatic stages of the disease in 
SCA2. In SCA2 reduction of sural SNAP is evident about 5 years prior to onset of symptoms 
and decreases further during the prodromal state and well into the disease [25, 27]. These 
studies suggest nerve conduction parameters as a potential biomarker for future interventional 
trials in presymptomatic states of SCAs. 
EMG depicts neuronopathy in patients with SCA1, SCA2, SCA3, and SCA7 [13]. Motor 
neuron affection is confirmed clinically by the presence of fasciculations. Neuropathological 
examination reveals loss of motoneurons in the anterior horns in SCA1, SCA2, and SCA3 [28].  
In summary, nerve conduction studies can help in the differentiation of ataxia genotypes by 
characterizing peripheral nerve involvement. Furthermore, electrophysiological parameters like 
compound muscle action potential (CMAP) and SNAP may serve as biomarkers indicating 
disease progression. However, before its use as outcome parameters in interventional studies 




Evoked potentials to sensory stimuli 
L. Schöls, Tübingen, Germany 
 
Evoked potentials frequently prove affection of the visual (VEP), auditory (BAEP), 
somatosensory (SEP) system in many subtypes of hereditary ataxia and reflect the wide spread 
of pathology in many of these disorders. This is especially true in the polyglutamine disorders 
SCA1, SCA2, SCA3 and SCA7 [10-12]. As for many of the rare genotypes, no representative 
data is available, and this overview is confined to SCA1, 2, 3, 6, and 7. 
Sensory evoked potentials (SEP) are challenging to assess in SCA as peripheral damage 
overlaps with disturbance of the central sensory tracts. Furthermore, it is technically difficult to 




































































responses that hinder proper recordings especially of peripheral components in fractionated 
SEP. This may well be the reason for the limited number of SEP studies in hereditary ataxias 
although they frequently reveal abnormal findings in SCA1 as well as in SCA2 and SCA3 [11, 
21, 25]. 
Abnormal visual evoked potentials (VEP) are a hallmark of SCA7 and reflect the retinal 
degeneration that goes along with ataxia in this subtype of SCA [29]. In other SCA genotypes 
VEP are more variably affected [10, 12, 25].  
Brainstem auditory evoked potentials (BAEP) are abnormal in the majority of patients with 
SCA2 and even in many presymptomatic mutation carriers [21, 25]. This finding matches well 
with the early and severe pontine atrophy seen on MRI in SCA2. In accordance with the 
widespread and severe neurodegeneration found in neuropathological studies also in SCA1 and 
SCA3, BAEP reveal brainstem affection also in many SCA1 and SCA3 patients [11, 21]. 
Whereas in SCA1, 2 and 3 frequently affect central parts of the auditory tract, in SCA6 
peripheral affection of the auditory system is more frequent [11, 21]. 
Studies of evoked potentials in genetically confirmed cohorts of autosomal recessive ataxias 
are exceptionally rare. Even in the most frequent subtype, Friedreich’s ataxia (FRDA), there 
are only few studies in genetically proven cases. Characteristic finding in FRDA is a loss of 
SEPs in combination with severe axonal sensory neuropathy [15, 30]. SEP findings are similar 
in ataxia with primary vitamin E deficiency (AVED) which is a phenocopy of FRDA [31]. In 
Ataxia telangiectasia (AT) SEP revealed common and severe affection of the sensory system, 
progressive over the course of disease and affecting both, the peripheral and the central sensory 
pathways. BAEP revealed only minor affection of the brainstem in some AT patients [32]. 
ARSACS is characterized by slowing of conduction in almost all fibre tracts resulting in 
prolonged latencies in VEP as well as BAEP and also SEP [20, 33]. 
In summary, although sensory systems are affected in many ataxia subtypes, systematic 




































































confirmed cohorts with a longitudinal assessment of evoked potentials are worthwhile to 
explore EP parameters as potential biomarkers to monitor disease progression in natural history 
studies as well as interventional trials. 
 
Transcranial magnetic stimulation (TMS)  
M. Branscheidt, P. Celnik, Baltimore, USA 
Transcranial magnetic stimulation (TMS) is a noninvasive technique that has been successfully 
used to investigate brain physiology in healthy individuals as well as in a wide range of 
pathological conditions. TMS can be used to determine different functional aspects of the motor 
system: integrity of the pyramidal tracts, balance of inhibition and excitation and the 
connectivity between different brain regions, including the connection between motor cortex 
(M1) and the cerebellum. Dysfunction of the pyramidal tracts is typically characterized as 
reduction in amplitude size or absence of motor evoked potentials (MEPs), and/or in increases 
in the central motor conduction time (CMCT). Imbalances in inhibitory and excitatory circuits 
can be probed by double-pulse paradigms, where a conditioning TMS stimulus precedes the 
test TMS stimulus. Of interest to this consensus paper, cerebellar-motor connectivity can be 
evaluated by applying a conditioning stimulus over the cerebellum prior to a test stimulus 
delivered to the contralateral motor cortex. In healthy controls this leads to a decrease of the 
MEP amplitude elicited from M1, a phenomenon termed cerebellar brain inhibition (CBI) and 
thought to be mediated by activation of the cerebellothalamocortical pathway. In this manner, 
several recent studies have used this measurement to read out the level of cerebellar activation 
in the context of different behavioral and/or cerebellar stimulation experiments [34, 35]. 
Because of its relative simplicity the CBI paradigm seems ideal to understand the 
pathophysiology of different neurological conditions that affect the cerebellum. For instance, it 




































































TMS measures have not yet found a clear clinical role in the pathophysiological understanding 
or diagnosing of ataxias.  
Motor evoked potentials, on the other hand, frequently prove affection of the corticospinal tracts 
in many subtypes of hereditary ataxias. MEPs might help dissociate different types of ataxia, 
and can detect pyramidal tract dysfunction even in the absence of clinical symptoms in some 
SCA subtypes [12, 38, 39].  
Motor evoked potentials have been studied foremost in the most common dominant ataxias. 
MEPs show that the corticospinal tract is frequently affected in SCA1, SCA2, SCA3, and SCA7 
[21, 30, 40]. Central as well as peripheral motor conduction time is prolonged especially in 
SCA1 and constitutes a distinct pattern separating SCA1 from SCA2, SCA3 and SCA6 [11, 21, 
41, 42]. Prolonged central motor conduction times have also been reported in SCA6 patients 
from Taiwan [43]. Furthermore, motor cortex activation is altered with an elevated motor 
threshold in SCA1 and SCA2 and reduced intracortical facilitation in SCA2 and SCA3 [30, 44]. 
MEP are abnormal even in the prodromal stage of the disease in presymptomatic carriers of 
SCA1, SCA2 and SCA3 mutations [38, 39, 45]. In prodromal stages of SCA1, MEP was shown 
to be affected before disease onset whereas SEP abnormalities developed with the onset of first 
symptoms and peripheral nerve involvement occurred only in early symptomatic stages of the 
disease [38].  
MEP data in recessive ataxias is limited. Characteristic findings in FRDA are prolonged CMCT 
or absent MEP [15, 30]. MEP data are not available in AVED [31]. SANDO with POLG 
mutations also shows severe sensory deficits and afferent ataxia but differs from FRDA 
electrophysiologically in that MEP are generally normal [16]. In Ataxia telangiectasia (AT) 
MEP were altered in 4/5 patients although clinical signs of cortico-spinal tract affection were 
missing [32]. ARSACS is characterized by prolonged latencies in MEP [20, 33]. 
TMS findings in ataxia, however, have not been consistent across studies. Restivio et al. [40], 




































































reported. Similarly, Farrar et al. [39] observed reduced intracortical inhibition and prolonged 
conduction times in patients with SCA3, while Schwenkreis et al. [30] showed significant 
reduction of intracortical facilitation and normal CMCT. The inconsistencies across studies 
might be due to the relatively small sample size, differences in disease stage and accompanying 
extracerebellar pathologies (e.g. Parkinsonism in SCA3). Changes in short interval cortical 
inhibition are altered in different pathologies to a similar extent, indicating low specificity of 
the method [46]. Thus, using TMS as a tool to elucidate differential diagnoses has been difficult 
[46]. 
Albeit the above-listed limitations, TMS might have a role as a complementary rather than a 
primary technique when it comes to differential diagnosis. For example, Schelhaas et al. [47] 
identified early-onset cerebellar ataxias clinically similar to Friedreich’s ataxia but without a 
frataxin gene mutation. In this subgroup neurophysiological testing using TMS revealed three 
distinct phenotypes which might inform future genetic testing. 
Assessing CBI introduces the possibility of differentiating conditions that cause ataxia due to 
involvement of afferent vs. efferent cerebellar pathways [48]. Patients with ataxia due to 
pathology of peripheral nerves or the posterior column or lesions of the middle cerebellar 
peduncle (afferent pathway) are more likely to show no changes in CBI. In contrast, patients 
with lesions of the cerebellum or the superior cerebellar peduncle, as well as patients with a 
degenerative cerebellar disease (SCA, MSA, paraneoplastic cerebellar atrophy, Wilson’s 
disease, efferent pathway) show decreased CBI (for an overview see [48]).  Moreover, these 
changes seem to follow the trajectory of disease progression, with pronounced decrease of CBI 
over time in degenerative ataxias versus normalization of CBI with recovery from acute 
cerebellar ataxia [49, 50].  
While these results are very promising, it has to be noted that the number of tested subjects 
remains very small and future research is needed to investigate factors that influence CBI in 




































































These two patients presented with predominant trunk and lower limb ataxia, while having only 
mild to absent upper limb involvement [51]. While the finding might explain that CBI follows 
somatotopic specificity rules [52], further characterization of this measurement in the context 
of patient populations is required to become useful in the clinical setting. 
In sum, to date, TMS has not been established as a diagnostic tool in ataxia and remains largely 
in the research phase. Data regarding the reliability, sensitivity, and specificity of TMS 
measures comparing healthy controls and the different forms of ataxia are scarce. However, 
TMS can be used to probe pyramidal tract involvement even before clinical symptoms become 
apparent, and therefore might help predict time to ataxia onset. Of note, it might provide 
diagnostic evidence when imaging findings are still unremarkable.  
CBI could also be useful to explore some of the pathophysiological mechanisms underlying 
different cerebellar diseases, to localize the anatomical origin of ataxias (efferent versus afferent 
pathways) and perhaps in the early differential diagnosis of Parkinson Plus Syndromes 
(especially MSA-C). Finally, theoretically, TMS could also be useful to monitor response to 
specific ataxia treatment interventions. Thus, TMS can potentially be developed into a 
promising screening and/or monitoring tool in ataxia, however further studies are needed to 
assess its sensitivity, specificity and predictive power in this patient population. Its application 
to investigate cerebellar connectivity and subclinical pyramidal tract involvement are especially 
intriguing in this context. 
 
Electroencephalography (EEG) 
H. A. G. Teive, L. de Paola, Curitiba, Brazil 
 
Autosomal recessive cerebellar ataxias (ARCAs) 
ARCAs encompass a heterogeneous group of usually early onset inherited ataxias, led by 
Friedreich´s ataxia (FRDA) and followed by ataxia telangiectasia (AT) [1]. Remillard et al. [53] 




































































abnormalities in 33% of patients, with abnormal slow or irregular background rhythms (30%), 
intermittent paroxysmal rhythms (8%), and unilaterally absent driving responses (4%). There 
was no response to intermittent photic stimulation in 60% of the patients. Only 8% of the 
patients reported epileptic seizures [53]. Autosomal recessive spastic ataxia of Charlevoix-
Saguenay (ARSACS) is rarely associated with epileptic seizures [54]. Anheim et al. [54] studied 
two patients from a French family with genetically proved ARSACS who, in addition to the 
classical phenotype, displayed asymptomatic generalized spikes and waves. Ramsay-Hunt 
syndrome (RHS) or progressive myoclonus ataxia (PMA), is a controversial group of diseases, 
characterized by the presence of progressive cerebellar ataxia, associated with myoclonus, mild 
epilepsy and cognitive dysfunction. In 2014, van Egmond et al. [55] described 5 RHS patients 
from the Netherlands (due to a homozygous mutation in GOSR2 gene - Golgi Qb-SNARE 
gene), presenting with progressive cortical reflex myoclonus, cerebellar ataxia, generalized 
epileptic seizures, and areflexia. EEG and EMG recordings demonstrated the presence of 
cortical spikes or spike-waves forms preceding myoclonic jerks.  
 
Autosomal recessive cerebellar ataxias  – Other diseases 
The progressive myoclonus epilepsy (PME) group defines a syndrome with myoclonus, severe 
epilepsy, progressive dementia and also cerebellar ataxia [56]. This group of diseases includes 
neuronal ceroid lipofuscinoses (NCLs), Lafora disease, Unverricht-Lundborg disease (ULD), 
myoclonic epilepsy with ragged red fibers (MERRF), among others. NCLs represent a group 
of hereditary diseases causing progressive neuronal degeneration, with dementia, refractory 
epilepsy, movement disorders, including cerebellar ataxia, and progressive visual impairment 
due to retinal dystrophy. In 2015, Canafoglia et al. [57] evaluated the electroclinical spectrum 
of the NCLs associated with CLN6 mutations. The authors describe an EEG pattern with slow 
and poorly organized EEG background, slow spike and waves and photoparoxysmal responses 




































































and spike-wave discharges proved rare, replaced by individual spikes with multifocal 
distribution. Lafora disease (LD) is an autosomal recessive inherited disease, characterized by 
the presence of myoclonus, epileptic seizures, visual hallucinations (occipital seizures), with 
progressive dementia and cerebellar ataxia [58].  Diagnosis is based on clinical and EEG 
findings and detection of two pathogenic mutations of two genes, EPM2A or EPM2B. The EEG 
typically shows slowing of background activity, paroxysms of generalized irregular spike-wave 
discharges with occipital predominance, and focal (occipital) abnormalities. ULD, a progressive 
myoclonic epilepsy type 1, is an autosomal recessive inherited disease characterized by the 
presence of stimulus-sensitive myoclonus, tonic-clonic epileptic seizures, and cerebellar ataxia 
[59]. Recently Gargouri-Berrechid et al. [59] analyzed the long-term evolution of EEG in 17 
patients with ULD. The most common EEG abnormalities were slow and disorganized 
background rhythms, with epileptic abnormalities in 47% of patients, including myoclonic jerks 
in 28%. Follow up EEGs, performed after regular treatment, showed improvement of 
background activity, with no epileptic abnormalities. The classic phenotype of Glucose 
transporter type 1 (GLUT1) deficiency syndrome (De Vivo disease) is characterized by 
infantile-onset epileptic seizures, delayed neurologic development, microcephaly, and 
movement disorders, including dystonia and cerebellar ataxia [60].  The patients commonly 
have a low CSF glucose concentration.  In 2005, Ito et al. [60] published an interesting case 
report of GLUT1 deficiency syndrome from Japan, in which pre-/postprandial EEG changes 
were demonstrated (with postprandial improvement compared to the EEG following an 
overnight fasting). They suggested that in children with epileptic seizures and unexplainable 
neurological deterioration, the CSF analysis and pre-postprandial EEG changes may be useful 
in diagnosing this potentially treatable disorder.  More recently, there is increasing recognition 






































































Spinocerebellar ataxias (SCAs) 
In 2005, Rakowicz et al. [62] evaluated 44 patients with SCAs type 1 and 2, providing data on 
clinical, electrophysiological and magnetic resonance imaging. EEG was performed but no 
significantly abnormalities were noted.  In 2012, Beluzzo et al. [63] published a case report of 
nocturnal frontal lobe epilepsy in a patient with SCA type 17. The awake scalp EEG was 
unremarkable, whereas the nocturnal video-electroencephalogram recording, demonstrated the 
epileptic seizure and EEG nonspecific abnormalities. SCA type 10, originally found in Mexico, 
has been described as a pure cerebellar ataxia associated with epileptic seizures (partial complex 
and generalized tonic-clonic) [64].  Rasmussen et al. [64] studied four Mexican families with 
SCA10, and epilepsy was found in 72.2% of patients  Grewal et al. in [65] evaluated clinical 
features and ATTCT repeat expansion in SCA10. The authors studied 2 large families with 
SCA10 and epileptic seizures were frequent with complex partial seizures, or complex partial 
seizures with secondary generalization, or generalized motor seizures (tonic-clonic), and in one 
patient status epilepticus was diagnosed. The EEG varied from normal to positive for focal or 
bilateral epileptiform discharges. Conversely, Teive et al. [66] described the clinical phenotype 
of five Brazilian families with SCA10 presenting with pure cerebellar ataxia but no associated 
epilepsy. In 2010 Teive et al. [67] studied the frequency of epilepsy in a large sample of 80 
Brazilian patients from 10 Brazilian families. Overall, the frequency of epilepsy was considered 
rare (3.75%). Two patients had generalized tonic-clonic seizures, and one patient had a 
combination of myoclonic, complex partial, generalized tonic-clonic seizures, with occasional 
status epilepticus. Interictal EEG of these 3 patients was abnormal in only one patient, showing 
diffuse disorganization but no clear cut epileptiform activity.  
Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare autosomal dominant 
neurodegenerative disease caused by an expansion of a CAG repeat in the atrophin-1 gene on 
chromosome 12 [68].  DRPLA is characterized by several combinations of cerebellar ataxia, 




































































phenotype may be similar to PME, PMA, Huntington´s disease (HD) and SCAs. The EEG 
abnormalities include burst of frontal and central slowing, with diffuse spike-wave complexes. 
Epileptic discharges may be induced by photic stimulation [68].  
Episodic ataxias (EA) 
EA-2 (CACNA1A gene), the most common syndrome, is characterized by episodes of 
cerebellar ataxia (with duration of hours to days) associated with interictal nystagmus and 
sometimes progressive ataxia. Associated symptoms are vertigo, nausea and vomiting, and 
migraine is found in 50% of patients. Some patients can also have progressive cerebellar ataxia 
and epileptic seizures. EA-3, EA-4, EA-7, and EA-8 (UBR4 gene) represent very rare forms of 
EA, and EA-5 (CACNB4 gene) can be associated with generalized epilepsy. EA-6 (SLC1A3 
gene) is associated with episodes of hemiplegia and seizures [69, 70]. Other genes associated 
with EA include ATP1A3, SLC2A1, FGF14 and PRRT2. PRRT2 (Proline-rich transmembrane 
protein 2) gene mutations can cause paroxysmal kinesigenic dyskinesia (PKD), infantile 
convulsions, epilepsy, migraine, and hemiplegic migraine [71]. In 1996, van Bogaert and 
Szliwowski [72] presented EEG findings in acetazolamide-responsive hereditary paroxysmal 
ataxia. The authors studied 6 family members, and intermittent rhythmic delta activity was 
found at rest in most patients, associated with less frequent low amplitude spikes. EEG 
abnormalities were activated by hyperventilation.  
 
Mitochondrial ataxias 
Mitochondrial ataxias represent a rare group of cerebellar and afferent ataxias due to 
mitochondrial DNA POLG gene mutations [1]. In general mixed ataxia is associated with 
peripheral neuropathy, external ophthalmoplegia, ptosis, and movement disorder, and epilepsy. 
Ekbom´s syndrome is a mitochondrial encephalopathy associated with mutation in the 
mitochondrial DNA, with cerebellar ataxia, cervical lipoma and photomyoclonus. The EEG 






































































For the most part, EEG findings are nonspecific. EEG, however, may play a potential role in 
the differential diagnosis of ARCA, PMA, PME (with cerebellar ataxia), SCAs, particularly 
SCA type 10, and mitochondrial and episodic ataxias.  
 
 
Speech assessments in ataxia 
A. P. Vogel, Melbourne, Australia 
Profound difficulties communicating affect the majority of people with a degenerative ataxia. 
Speech severity also correlates with clinical characteristics such as disease duration and severity 
[74, 75] making it a viable proxy of degeneration [76, 77] and treatment response [78].  
Speech in Friedreich’s ataxia (FRDA) and spinocerebellar ataxias (SCA) is characterised by 
reduced or uncontrolled variation in pitch and loudness, a slower rate of speech and articulatory 
timing [79], imprecise production of consonants and vowels, dysphonia [80], impaired nasality 
[81], abnormal resonance [81] and reduced intelligibility [74, 75]. These deficits worsen over 
time [76], however no natural history studies have looked at devolution of speech beyond four 
years. The exact prevalence of dysarthria in these populations is unknown, however evidence 
from FRDA suggests that all individuals with a disease duration longer than four years present 
with dysarthria [74]. Efforts to use speech as a differential diagnostic tool have proven difficult 
with a relative absence of adequately powered data on neurodegenerative ataxias [82, 83]. 
Nevertheless, current evidence suggests that regularity of alternating and repeating syllables 
(diadochokinesis; DDK) is markedly impaired in SCA3, whereas individuals with SCA6 can 
present with more pronounced deficits in speech rate and pitch and loudness variation [82]. 
With this information in mind, these deficits are also observed in other hereditary ataxias 
including FRDA and POLG associated ataxia [84] with some studies proposing that specific 







































































The tasks used to assess speech in ataxia in daily practice are ideally objective,  need to be 
stable in the absence of change and sensitive to disease progression or treatment response [85, 
86]. Protocols can include examination of the underlying oral musculature structure and 
function, listener based ratings of impaired speech features, patient self-report, and objective 
acoustic analysis to quantify change over time (see Table 3). Aspects of this protocol were 
chosen for their utility (e.g., ease of use, administration time, clinical information provided etc.) 
and psychometric properties (e.g. reliability, validity). Acoustic analysis of speech provides an 
objective adjunct to listener based judgements of speech precision and clarity. Acoustic analysis 
uses a combination of spectrographic and waveform (among other modalities) analysis of the 
physical properties of sound production to provide information on vocal output. Analysis of 
fundamental frequency (acoustic correlate of pitch), for example, is estimated from the number 
of vocal fold pulses the larynx produces within a second and validated against ground truth data 
derived from electroglottography (EGG) [87]. Other acoustic analysis metrics tap into different 
neurophysiological responses of disease such as speech related timing deficits [88].  
There is not an established ataxia-specific speech protocol, however. One that considers tasks 
with varying levels of complexity (cognitive load) can assist in determining the basis of changes 
to speech (i.e., cognition or motor decline) [89, 90]. Example tasks increasing in complexity 
include: i) a sustained vowel /a/, ii) diadochokinesis (DDK) tasks (eg. pata within SCAFI), iii) 
reading, and iv) unprepared monologue or conversation. Variations of this protocol have been 
applied in ataxia [74] and other neurodegenerative diseases [91] with demonstrated stability 
and sensitivity [86, 92]. It is recommended that speech recorded for perceptual and acoustic 
analysis is acquired using a high quality equipment (see [93] for tutorial on hardware options). 
This approach reduces noise in the recorded signal allowing accurate mapping of the acoustic 
signal designed to pick up perturbations in the voice. Acoustic data can be derived using 




































































KayPentax). Basic acoustic outcomes for ataxia can include measures of timing (e.g., speaking 
rate (syllables/total signal time), mean pause length [88]), vocal control (e.g., variation of 
fundamental frequency or intensity) and quality (e.g., harmonics to noise ratio). 
 
Current state of play 
Speech assessment protocols currently used in clinical practice rely heavily on the expertise 
and experience of the clinician to make judgements about the speaker. They are limited by their 
subjectivity and poor inter-rater reliability. Listener derived examinations are well suited for 
describing the characteristics of a speech disorder but are limited in their capacity to objectively 
describe changes resulting from neurodegeneration or treatment response. Further, few clinical 
exams include formalised assessments of the impact of dysarthria on the patient. We suggest 
clinical researchers employ brief but repeatable tests of speech that utilise acoustic analysis to 
objectively measure change in production combined with standardised self-report measures on 
speech-related quality of life and listener based judgements on set tasks of varying complexity. 
The future with speech acquisition and analysis lies with remote capture and monitoring of 




Gait assessments in cerebellar ataxia 
W. Ilg, Tübingen, Germany  
Ataxic gait is typically characterized by an increased step width, variable foot placement, 
irregular foot trajectories and a resulting unstable, veering navigation with high movement 
variability [97-99] and a high risk of falling [100]. Causes for ataxic gait can be varied, 
including focal cerebellar disease such as stroke, cerebellar tumors, multiple sclerosis, and 
degenerative diseases affecting the cerebellum or its afferent pathways (see [99] for a more 
detailed description). For the most common autosomal dominant spinocerebellar ataxias 




































































In the clinical setting, ataxia symptoms are rated commonly using clinical ataxia rating scales 
like ICARS [103] and more recently SARA [104]. Both scores include, in a semi-quantitative 
way, stance, the assessment of a ten meters gait test including a half-turn, and execution of 
tandem gait. Ratings are based on the ability of free walking, the judging of the amount of 
staggering and the counting of missteps for the tandem walk. Both scores, ICARS and SARA, 
include subcategories for gait&posture (e.g. SARAposture&gait ≡ sum of the three SARA items: 
gait, stance, and sitting) [104, 105], which have been examined as progression marker of gait 
impairments [106] or as outcome marker for gait rehabilitation studies [107, 108]. In addition 
to the clinical ataxia scores, additional scores are used to describe the ability of balance and gait 
control in scenarios relevant to everyday life. Common examples and are the self-report of 
balance confidence in everyday life activities using the Activity-specific Balance Confidence 
Scale (ABC) [109], the dynamic gait index [110] and BESTest [111], testing more complex 
gait behaviour including walking over obstacles and walking up stairs.  
Quantitative assessments  
Quantitative gait assessments and the analyses of spatio-temporal characteristics of ataxic gait 
patterns have been conducted in order to examine the underlying pathological control 
mechanisms and to perform a more fine-grained and objective characterization of ataxic gait. 
Several studies of  ataxic gait reveal that gait features like decreased velocity and step length as 
well as increased step width and step cycle time might reflect predominantly cerebellar-
nonspecific safety strategies rather than discrete deficits in control [112-116]. In contrast, the 
most striking and distinctive features of ataxic gait on the kinemetic level seem to be the high 
variability in several spatial and temporal gait features (e.g. variability in step length, step width 
and gait cycle time) [112-114, 117, 118]. 
The spatiotemporal structure of ataxic gait has also been characterized on the level of leg muscle 
activity. A considerable widening of EMG bursts and significant temporal shifts in the center 




































































mid-stance [119]. Abnormalities in intersegmental coordination have been identified associated 
with these changes in the leg muscle activity pattern. In addition, an abnormal transient has 
been found in the vertical ground reaction force and instability of limb loading at heel strike. 
In Friedreich´s ataxia, lower limb spasticity has been identified in gastrocnemius and soleus 
muscles as a sensitive measure which is evident early in the disease and correlated to gait 
impairments measured by functional gait scores [120]. 
 
In summary, the observed characteristic high variability of walking patterns is most likely due 
to the complex interaction between cerebellar-induced deficits in balance control [115, 121] 
and multi-joint coordination [112], used safety strategies and inaccurate adjustments to 
appearing losses of balance. Consequently, this results in a continuous step-by-step adjustment 
of the gait strategy, making it demanding to quantitatively describe the actual walking 
behaviour of ataxia patients [114].  
As gait features describing disease progression, velocity and mean step length as well as step 
length variability have been identified [106, 122]. Most of these progression markers show 
correlations with the changes in SARA or ICARS scores for patient populations from moderate 
to more severe ataxia. 
In addition to these patient populations, an emerging research topic including the assessment of 
ataxia-related movement changes presents the pre-clinical stage of degenerative cerebellar 
ataxia, the phase before clinical manifestation of the disease [123]. As this stage provides a 
promising window for future early therapeutic interventions [124], there is a need for measures 
which can sensitively identify and quantify progression and intervention benefits in the 
preclinical stage. By their nature, clinical scores lack the sensitivity to quantify subtle 
movement changes [125]. A recent study on mutation carriers of autosomal dominant 
spinocerebellar ataxias has delivered evidence, that spatio-temporal gait features in complex 




































































in mutation carriers without any clinical gait sign, several years before clinical manifestation 
[126]. Thereby, features like the temporal variability of gait cycles have shown to be 
distinctively more sensitive in identifying early behaviour changes in tandem walking in 
comparison to counting missteps, like used in clinical rating [27, 104]. An overview of studies 
using quantitative gait assessment in cerebellar ataxia can be found in Table 4. 
Motivated by emerging research questions like finding objective evaluations of intervention 
outcome, there is an increasing demand for quantitative movement assessments also in clinical 
centres which do not have an advanced motion lab with an elaborated whole-body motion 
capture system.  Alternative systems are pressure sensitive mats to analyse spatio-temporal step 
parameters (e.g. step length and time) [127-129], affordable camera-based systems [130, 131], 
or portable inertial sensors which are used for instance for instrumented Timed Up and Go tests 
[132]. Future studies, have to validate the application of such quantitative assessments in multi-
centre environments.  
Gait rehabilitation  
Although benefits of motor rehabilitation in degenerative cerebellar disease have been 
discussed controversially for a long period [133, 134], recent studies reach more and more 
common acceptance, that continuous motor training can improve gait function in degenerative 
patients, for instance by increasing gait velocity and decreasing step variability and body sway  
[107, 135-139].  
Analyzing gait and falls in everyday life  
Increasingly more attention attracts the analysis of patients’ behaviour in everyday life. First 
studies documented the falls and identified measures in quantitative gait assessments like 
increased step length variability, which are associated with increased fall risk [128, 140]. Other 
approaches documented the ambulatory activity with portable inertial sensors as an progression 




































































characterization of ataxia-related spatio-temporal gait features in more unconstraint 
assessments and ultimately in everyday life.  
Conclusions 
The quantitative assessment of gait is less important for differential diagnosis but serves as a 
very relevant progression marker as well as an important measure for the rating of intervention 
benefits relevant for everyday life.   
 
 
Measuring postural control  
FB Horak, Portland, OR, USA 
Balance disorders due to impaired postural control are inevitable in patients with ataxia and 
have severe consequences. Falls and fall-related injuries are common with 84% of cerebellar 
ataxic patients reporting at least one fall per year and 74% reporting fall-related injuries  [100, 
154].  Although nonataxia symptoms in patients with cerebellar involvement, such as pyramidal 
weakness or spasticity, also contribute to falls, ataxia is associated with hypermetria as well as 
sensory integration and multisegmental coordination deficits that directly contribute to falls by 
impairing control of postural equilibrium and orientation. 
Ataxia impairs several, independent domains of postural control, including: 1) postural sway 
in stance, 2) anticipatory postural adjustments (APAs), and 3) postural responses to external 
perturbations (APRs). Evidence for impairments in each of these domains of postural control 
come from laboratory studies using force plates to quantify hypermetric center of foot pressure, 
surface electromyography to measure intramuscle temporal coordination, and motion capture 
to characterize control of body center of mass by whole body kinematics. Control of postural 
sway in stance involves the integration of sensory information from proprioception, vision and 
vestibular systems and reweighting dependence upon these sensory systems when sensory 
conditions change [155]. APAs are preprogrammed postural strategies that precede fast, 




































































multisegmental postural muscle synergies at 100 ms to recover from accidental slips and trips 
and pushes [157]. Ataxia-related hypermetria, impaired sensory integration, and 
multisegmental coordination affect all of these domains of postural control. 
Postural sway in stance is significantly larger in the majority of people with cerebellar ataxia 
than in age-matched control subjects [158]. The first quantitative study of the effects of 
cerebellar ataxia on postural sway using force plates found that 86% of subjects showed larger 
than normal sway path and/or sway area [159]. However, the particular, abnormal frequencies 
of sway depended on what parts of the cerebellum were involved. For example, spinocerebellar 
ataxia from Friedreich’s ataxia results in excessive sway at low frequencies (0.1-1 Hz), whereas 
anterior lobe deficits result in excessive sway at higher frequencies (2-4 Hz) that has been called 
‘postural tremor.’ The increase in lower sway frequency may be due to slowed proprioceptive 
conduction resulting in delayed closed loop feedback control of postural sway. In contrast, the 
increase in higher sway frequency may be due to excessive use of the hip strategy, rather than 
ankle strategy, for control of posture [160]. 
The increase in postural sway in cerebellar, compared to control, subjects is enhanced by eye 
closure, in all but subjects with vestibulocerebellum involvement [159]. Vestibulocerebellar 
involvement apparently prevents use of vision for postural stability and perception of verticality 
as these patients not only sway more, but may also tilt their trunk to one side, even with eyes 
open. The exaggerated dependence upon vision for postural control in the majority of ataxic 
patients is likely a compensation for impaired use of proprioception due to spinocerebellar 
proprioceptive involvement. When the vestibulocerebellum is involved, ataxic patients also 
show even larger differences in sway from controls when they need to use vestibular 
information for postural control, e.g. when standing on a compliant surface or with a narrow 
base of support with eyes closed [161-163]. These difficulties suggest that the 
vestibulocerebellum is important for using vestibular information to control postural orientation 




































































Postural instability in ataxic patients is characterized by large trunk displacements, velocities, 
and accelerations and exaggerated ankle roll instability, quantified with motion capture. This 
instability is likely due to both hypermetric postural responses, as well as delays in the closed-
loop feedback control of sway.  Despite their larger sway, cerebellar ataxics reduced that sway 
more than control subjects when diverting their attention to a cognitive task under dual task 
conditions [164]. This exaggerated reduction in sway during a dual task is thought to be due to 
a maladaptive increase in muscle co-contraction because it was also associated with more falls 
under challenging stance conditions [164]. 
Anticipatory postural adjustments are present, though impaired, in people with cerebellar 
ataxia, suggesting that the cerebellum is not critical for their development or storage. However, 
later onsets and disrupted intra-limb and multisegmental timing of muscle activity suggests the 
cerebellum is involved in muscle activation timing for refined movement metria. For example, 
activation of tibialis anterior as an APA prior to rising onto toes has a longer latency, is more 
variable and tonic, rather than phasic burst, in subjects with ataxia [165]. APAs that shifted the 
center of pressure laterally and forward prior to a voluntary step were also present in subjects 
with ataxia and could be modified by external feedback, but did not scale with anticipation of 
external feedback [166]. The first step size and speed was slower than controls, however, and 
may be compensatory for impaired APAs. Similarly, APAs in the legs associated with sudden 
release of a load to the arms showed intact muscle activation patterns but with more 
cocontraction and background muscle activation [167]. However, a recent study showed 
impaired temporal coordination and long latencies of proximal arm muscles associated with 
fast finger flexion in supported sitting, suggesting that intralimb coordination is affected [168]. 
Automatic postural responses to external perturbations in people with cerebellar ataxia have 
normal latencies with hypermetric response size, abnormal multisegmental coordination and 
impaired adaptation to anticipated changes in perturbation characteristics. The short and 




































































regardless whether the direction of surface displacement is a translation or rotation, predictable 
or randomly presented [169-171]. Normal latencies of postural muscle responses to 
proprioceptive stimuli suggest that the cerebellar feedback loop is not critical for triggering or 
creating the synergy patterns of these rapid postural responses. However, postural response size 
is hypermetric in ataxia, resulting in postural instability, sometimes resulting in falls in the 
opposite direction of the perturbation. Postural responses to both slow and fast surface 
translations or rotations often result in falls, with large trunk displacements. The longest latency 
responses to perturbations are especially exaggerated in size and duration, perhaps to 
compensate as antagonists to the hypermetric agonist responses [159, 170, 172]. Abnormal 
multisegmental coordination is apparent in postural responses also, characterized in excessive 
locking of the knees, resulting in trunk instability. 
In addition to hypermetric postural responses, the size of the postural response, both center of 
pressure displacement and muscle activation, does not adapt to predicted, upcoming postural 
perturbation size [170]. A follow-up study showed that although cerebellar ataxics could predict 
the amplitude of postural perturbations based on prior experience, they could not scale up or 
down the size of postural responses based on this prediction [173]. Surprisingly, postural 
response size could be reduced with repetition (habituation), despite the difficulty increasing 
and decreasing postural response magnitude based on predicted perturbation size. These results 
suggest that the cerebellum plays a critical role in adapting postural response size based on prior 
experience, and hypermetric postural responses may be related to this deficit. 
 
Evaluate ataxia of posture in a clinical setting 
Ataxia has a profound effect on the ability to stand, especially when sensory information from 
vision is reduced and with a narrow base of support. Thus, the most sensitive tests of ataxia of 
posture control involve standing with eyes closed and with the feet together, tandem, and on 




































































vision available is included (Romberg ratio) to focus on the ability to control standing balance 
when somatosensory and visual inputs must be relied upon. Sitting balance without back 
support, and sometimes without foot support, is useful for patients who cannot stand 
unsupported. Because anticipatory postural adjustments are hypermetric, it can also be helpful 
to examine standing balance associated with rapid, voluntary movements such as step initiation, 
stepping onto a stair, bilateral arm raising with weights [111]. Ataxia is seen as excessive trunk 
instability due to inappropriate anticipatory muscle activation in the legs and trunk. Because 
postural responses are hypermetric, a manual ‘Push and Release test’ can be used to examine 
the ability to take a single step to recover equilibrium in response to external perturbations 
[174]. A patient leans into the examiner’s hands on their scapula just until their body weight is 
supported, before a rapid release of force. Ataxia is seen as rapid stepping with abnormal, lateral 
stepping and excessive trunk disequilibrium in response to release from a backward lean. 
The quiet stance, anticipatory postural adjustments and postural responses mentioned above 
can easily be quantified in clinical environments using body-worn, inertial sensors (IUMs) 
[175]. For example, a 2-axis accelerometer on the lumbar segment can be used to quantify 
anterior/posterior and lateral postural sway area, velocity and frequency during quiet stance in 
standing or sitting [176]. Ataxia is reflected in larger than normal sway area, velocity and 
frequency but the direction of the excessive sway depends upon the type of ataxia [159].  A 
Romberg quotient with sway area eyes closed/eyes open larger than 1.5 would be considered 
abnormal. Quantification of postural sway allows for more sensitive measures of subtle 
impairment and more sensitive measures of change in postural control than rating scales.  
Recently, anticipatory postural adjustments have also been quantified with an IMU on the 
lumbar segment and legs to substitute for the traditional laboratory center of pressure measures 
[176]. The Push and Release test has also been instrumented with body-worn, inertial sensors 
to quantify postural response latency, compensatory step size and speed, and time to recover 




































































measure quiet stance duration under challenging conditions, such as the feet together, eyes 
closed condition. In addition, body-worn sensor technology will soon be available to quantify 
ataxic hypermetria of postural sway, anticipatory postural adjustments and postural responses 
quickly in the clinic. Instrumented tests have the advantage of being more sensitive and specific 
than clinical tests, albeit with added time and expense. 
 
Eye movements: Saccades 
A. Butala, D.S. Zee, Baltimore, USA 
Saccades are fast and fleeting, minimizing the time retinal image smearing precludes useful 
vision. The intrinsic association with vision and direction/initiation of attention means saccades 
have widespread cortical localization including every lobe of the cerebral cortex, limbic 
regions, and basal ganglia. The superior collicus (SC) is the final conduit to the brainstem and 
the substantia nigra pars reticulata (SNpr) helps gate a decision process about “what to look at” 
and “when.” The cerebellum plays a key role as the monitor of the accuracy of movements of 
all types, and accordingly, assures saccade accuracy in the face of normal development, aging, 
disease or trauma. Saccades are biomarkers extraordinaire for investigating physiology, 
cognitive functions, as well as pathophysiology and diagnosis of disease. The characteristics of 
saccades, especially speed and accuracy, are easy to evaluate and have specific anatomical, 
pathological correlations that are useful clinically [180].  
The premotor commands that drive the ocular motor neurons to generate the saccade are 
produced by burst neurons within the pons in the pontine paramedian reticular formation 
(PPRF) for horizontal saccades and within the midbrain in the rostral interstitial nucleus of the 
MLF (riMLF) for vertical saccades.  
 
The cerebellum and saccades 
The ocular motor vermis (lobules 5-7) (OMV) and its underlying projection site in the posterior 




































































cerebellum that control saccades. The FOR projects to the brainstem saccade generators and, 
acting as a brake, terminates the burst neuron discharge when the saccade reaches its target goal 
[181]. Since Purkinje cells inhibit their target neurons in the deep nuclei, the effects of deep 
nuclei lesions are the reciprocal of vermal lesions. Accordingly, lesions of the FOR lead to 
saccade overshooting or hypermetria while lesions of the overlying dorsal vermis lead to 
saccade undershooting or hypometria. Each FOR acts to inhibit ipsilateral saccades and 
promote contralateral saccades so that unilateral dysfunction of the FOR leads to overshooting 
of ipsilesional-directed saccades. Likewise, each side of the cerebellar vermis acts to facilitate 
ipsilateral saccades and inhibit contralateral saccades so that unilateral dysfunction of the 
vermis leads to undershooting of ipsilesional-directed saccades [182]. Thus, depending on the 
relative degree and asymmetry of cerebellar malfunction, different patterns of saccade 
dysmetria can appear. In contrast, saccade speed and saccade initiation (latency) are little 
affected by lesions restricted to the cerebellum. Some parts of the cerebellar hemispheres 
adjacent to the OMV and their projection sites in the more lateral cerebellar deep nuclei may 
also be involved in higher-level, more voluntary control of saccades, e.g., antisaccades but these 
types of abnormalities are not easily appreciated clinically [183].  
 
Clinical examination of saccades and considerations on saccade pathology and localization 
[184]  
Range of motion  
The first consideration in the assessment of saccades is whether there is a primary problem with 
the eye muscles themselves that is limiting the range of motion. To assess range, ask the patient 
to look in the nine cardinal directions of gaze. If there is a limitation of range a supranuclear 
process must be excluded, using other stimuli, such as a slowly moving target, optokinetic tape 
or mirror, or passive head rotations, to show that the range of motion can be improved using 




































































deficit. A typical example is a restriction of voluntary vertical gaze in patients with the 
Richardson variant of progressive supranuclear palsy (PSP) or Niemann Pick type C, both of 
which conditions may have ataxia as a prominent component. Range of motion of ocular 
movements is readily assessed by several methodologies reviewed later. 
Velocity 
Reduced velocity of voluntary, visually-guided saccades is appreciated when patients are asked 
to make saccades between two relatively widely-spaced targets, such as between the examiner’s 
finger, placed eccentrically, and the examiner’s nose. Slow horizontal and slow vertical 
saccades result from lesions affecting burst neurons within the PPRF and riMLF, respectively. 
Typical examples are: slowing of horizontal saccades in spinocerebellar ataxia type 2 (SCA2) 
[185]  and of vertical saccades in Whipple's disease, Niemann-Pick type C [186] and  PSP 
[187]. Quantification of saccade speed with recording devices can document slowing of 
saccades. The normal peak velocity – amplitude relationship for saccades is known as the “main 
sequence.” Unfortunately, the range of maximum peak velocities in normal subjects is wide so 
that multiple measures over time are often required to document a progressive decrease in 
saccade speed. Velocity and trajectory measurements require high bandwidth (150 – 300 Hz) 
for accurate and reproducible results.  
 
Accuracy 
Saccade accuracy is examined similarly, asking the patient to make saccades on command to 
the eccentrically located finger and then back to the examiner’s nose in both hemifields of gaze. 
Corrective saccades are the signature of dysmetria as one infers whether the first saccade was 
hyper- or hypometric based on the direction of the correction. Extreme hypermetria, usually 
with fastigial nucleus lesions, leads to macrosaccadic oscillations in which case repetitive, 
overshooting saccades take the eyes back and forth about the position of the target as a saccade 




































































in the dorsal vermis. Similar to speed assessment, accurate gain measurement requires high 
bandwidth temporal resolution oculography. 
Initiation 
Saccade initiation defects, resulting in increased saccade latency, are only appreciated at the 
bedside if they are marked, and are best quantified with eye movement recordings. Increased 
latencies are not a feature of pure cerebellar disease, but imply cerebral hemisphere or basal 
ganglia disturbances [e.g., ataxia telangectasia (AT) or ataxia with oculomotor apraxia (AOA)]. 
Patients with saccade initiation defects often have conspicuous overshooting head movements 
and are mislabeled as having an apraxia [188]. Prolonged latency, lasting milliseconds, 
necessitates high temporal resolution detection coupled against prompted visual stimuli. 
 
Saccade testing batteries 
Since an early cerebellar component is often a feature of many neurodegenerative disorders that 
also involve the cerebral hemispheres, basal ganglia or brainstem it is important to evaluate eye 
movements in ataxia patients in the context of what might be accounted for by extracerebellar 
pathology. A battery of testing paradigms (antisaccades, memory-guided saccades, scanning 
saccades, sequence of saccades, predictive saccades, etc.) is available, and certain patterns of 
saccade abnormalities often help in localization and diagnosis. These types of abnormalities are 
best appreciated when eye movements are recorded and quantified in response to carefully 
controlled stimuli. Contemporary, non-invasive, video-based, recording techniques are well 
tolerated, easily applied and quantitative [189] integrating both high-temporal and spatial 
resolutions required for reproducible and accurate measurement. Typical examples of patterns 
of abnormalities of saccades associated with extracerebellar deficits include: 1) the relative 
sparing of reflexive saccades to a novel stimulus versus difficulty in making internally-
generated saccades, rapidly back and forth, between fixed stationary targets, as occurs in 




































































saccades and incessant, prominent horizontal saccade intrusions (square-wave jerks) in 
progressive supranuclear palsy, and 3) marked inability to suppress reflexive saccades toward 
a novel visual stimulus when the instruction is to look away, at the mirror location, from the 
visual target (the antisaccade test) as occurs in Huntington’s disease [190].  
To reiterate the main points about saccades and cerebellar disease: Inaccuracy is the most 
prominent and consistent sign of saccade dysfunction in cerebellar disease. Saccade inaccuracy 
can usually be discerned at the bedside with simple visual inspection and is also easily 
quantified with eye movement recordings. Slowing of saccades can often be appreciated at the 
bedside, but subtle degrees require quantification with eye movement recordings. Slow 
saccades imply pathology in the brainstem reticular formation where premotor commands are 
generated. Defects in saccade initiation are not a feature of pure cerebellar disease. They are 
usually best appreciated by measuring latencies with eye movement recordings.  
 
 
Eye movements: Vestibulo-ocular reflex (VOR) 
A. Butala, D.S. Zee, Baltimore, USA 
A careful examination of the vestibular system is essential for the evaluation of cerebellar 
ataxia. Not only do cerebellar lesions often lead to vestibular abnormalities, but many ataxia 
syndromes are associated with profound loss of vestibular function, which has both diagnostic 
and therapeutic (for rehabilitation) implications. The advent of new bedside clinical 
examination techniques and easy-to-use video-oculography (VOG) has made the clinical and 
quantitative evaluation of the vestibular system easy. 
The most primitive part of the cerebellum – called the archi- or vestibulocerebellum – is 
extensively interconnected with the vestibular and other brainstem nuclei and also receives 
afferents directly from the labyrinth. Thus, it is not surprising that vestibular dysfunction is 




































































cerebellum are the flocculus, paraflocculus (tonsil), ventral uvula, and nodulus. These structures 
project to the deep cerebellar nuclei and directly to the brainstem vestibular nuclei, where they 
can influence the direct, three-neuron arc of the vestibulo-ocular reflex (VOR) as it traverses 
the brainstem. We emphasize three key vestibuloocular reflexes: 1) the rotational VOR, 
responding to angular acceleration sensed by the semicircular canals (SCC), transduces head 
rotation,  2) the translational VOR, responding to linear acceleration sensed by the otolith 
organs, transduces head translation and 3) the ocular counter-rolling (torsion) reflex (OCR), 
responding to the change in linear acceleration associated with static tilt of the head with respect 
to gravity. The OCR reflex, which aims to keep the retina aligned with the direction of the pull 
of gravity, is vestigial in humans but in pathology often becomes a prominent source of 
symptoms with accompanying corresponding signs. Positional nystagmus is another common 
finding in ataxia patients. It is caused by an abnormal response to the change in linear 
acceleration when the head is tilted with respect to gravity.  
Disturbances of vestibular reflexes can be static, i.e., with the head still, when there is a tone 
imbalance in the resting activity of the vestibular nuclei. They are manifest as spontaneous 
nystagmus due to imbalance in semicircular canal activity, and a subjective tilt of the visual 
world [with associated counterrolling (torsion) of the globes] from imbalance in utricular 
activity. With ocular counterolling there may also be a head tilt and skew deviation (vertical 
misalignment of the eyes). This constellation of signs is known as the ocular tilt reaction (OTR) 
[191].  
Dynamic imbalance occurs during head rotations or translations when the response of the VOR 
does not match what is needed to compensate correctly for the associated head motion. This 
leads to blurred vision (oscillopsia) during head movement. Dynamic disturbances can be 
related to hypofunction (e.g., a loss of labyrinthine responsiveness), hyperfunction (e.g., 
increased amplitude of response as can occur in cerebellar disease) or misdirected responses 





































































Clinical examination of the VOR: pathological correlates  
Static disturbances 
Spontaneous nystagmus, as an indicator of a static vestibular imbalance in the SCC, is best 
looked for first with fixation eliminated (e.g., using lenses which blur the patient’s view) and 
then compared with fixation allowed. With many central lesions, including cerebellar disease 
involving the flocculus and paraflocculus (tonsil) there is a failure of the normal ability to use 
vision to suppress an unwanted spontaneous nystagmus. This abnormality is closely tied to 
coexisting defects in smooth pursuit and cancellation of vestibular responses when patients 
track targets moving with the head. Many such patients also have a spontaneous downbeating 
nystagmus that is usually not suppressed by visual fixation. It likely reflects an imbalance in 
the inhibitory cerebellar influences over vertical semicircular canal pathways in the brainstem. 
Gaze-evoked nystagmus on attempted far lateral gaze often occurs with downbeat nystagmus 
and impaired smooth pursuit;  together these are the characteristic eye movement abnormalities 
associated with the lesions in the flocculus/paraflocculus (tonsil) [192].  
Ocular counter-rolling (torsion) is an indicator of a static vestibular imbalance in the otolith 
system It is best inferred from measuring the subjective visual vertical (SVV). In this test, a 
patient is instructed to orient a vertical line parallel to their subjective sense of upright. It is 
readily performed at the bedside with the bucket test [193] in which patients must report when 
a line appears to be upright with no other visual cues available. The actual orientation of the 
eyes may be measured with fundus photography or various video methods [194]. Another 
feature of otolith imbalance may be a skew deviation (vertical misalignment of the eyes) that 
reflects the emergence of a phylogenetically-old, ocular righting response of a lateral-eyed 
animal in response to lateral tilt of the head. Coupled with the ocular torsion, there is often tilt 




































































commonly occurs with lesions in the brainstem though less frequently with isolated cerebellar 
lesions. 
Dynamic disturbances 
Assaying dynamic function of the VOR is centered around comparing the amplitude (and 
direction) of the compensatory eye movement, the slow-phase, to that of the stimulus, head 
motion. Quantitatively, is the gain (output eye movement /input head movement) = 1.0? One 
may begin with testing dynamic visual acuity (DVA). With the patient viewing a distance acuity 
chart and the head stationary, the lowest line the patient can read is ascertained. Then acuity is 
measured while shaking the head horizontally and then vertically at a frequency of  at least 2 
Hz. One notes the number of lines on the acuity chart lost with head shaking; more than two is 
abnormal. More objective and quantitative testing can be obtained by recording head 
movements and only displaying the acuity optotypes when the head has reached a specific speed 
[195, 196]. 
Head impulse test (HIT) 
Next, the VOR is assessed using the head impulse test (HIT) in which the subject fixes on a 
stationary object (such as the examiner’s nose) during a brief but high-acceleration movement 
of the head imparted by the examiner. The examiner monitors for corrective saccades (e.g., if 
the reflex is hypoactive the eye moves away from the point of fixation and a corrective saccade 
opposite to head rotation is needed to bring the fovea back to the center target). These corrective 
saccades can be overt, occurring after the head movement and easily seen on simple visual 
inspection, or covert, taking place during the head movement and difficult to discern by eye.  
While subject to artifacts, VOG goggles can still be used to quantify reliably both the gain of 
the slow phase and any corrective saccades [197-199]. In cerebellar disease, these measures of 
the VOR become excellent biomarkers for diagnosis (both acutely and chronically), progression 




































































Neuropathy, Vestibular Areflexia Syndrome (CANVAS) in which there is profound loss of 
labyrinth function [202]. 
A common vexing clinical scenario which illustrates the practical use of the HIT is the 
determination whether a patient with acute onset isolated vertigo and spontaneous nystagmus 
has a stroke. These patients usually have a benign viral affliction of the inner ear but 
occasionally these symptoms herald a cerebellar infarction. Quantification of the HIT with 
VOG helps to determine whether the lesion might be central, and in some patients, points to 
which particular part of the cerebellum is at fault [203]. A positive HINTS algorithm – head 
impulse negative, nystagmus that changes direction depending on eccentric gaze direction and 
a skew deviation –  argues for a central lesion and patients must be evaluated for a stroke. 
Lesions of the flocculus (supplied by the anterior inferior cerebellar artery) are associated with 
decreased head impulse responses, while lesions in the tonsil and ventral uvula/nodulus 
(supplied by the posterior inferior cerebellar artery) are not. Another feature of the HIT response 
that points to cerebellar dysfunction is cross-coupling, i.e., the slow-phase response has a 
component that is not in the same direction as the head rotation. The most common pattern is 
an upward slow phase (and downward correction) with horizontal head rotations; this localizes 
to lesions in the vestibulocerebellum [204]. 
Head-shaking induced nystagmus and tilt suppression of post-rotatory nystagmus 
Two other dynamic tests are particularly useful for analysis and localization of cerebellar 
dysfunction: post head-shaking induced nystagmus and tilt suppression of post-rotatory 
nystagmus [205]. Both are best evaluated using quantitative VOG. With a unilateral peripheral 
lesion, there is often a transient horizontal nystagmus following a short period (10-15 secs) of 
brisk (2 Hz) horizontal head-shaking. The slow phases are directed toward the side of the 
hypofunctioning labyrinth. With cerebellar lesions and especially when the nodulus/uvula is 
affected the post-head shaking nystagmus usually has different characteristics; a vertical 




































































nystagmus. Tilt suppression of post-rotatory nystagmus is also abnormal with uvula-nodulus 
lesions; there is a loss of the normal suppression of post-rotatory nystagmus when the head is 
tilted just after the chair stops rotating (as reflected in the time constant of decay of post-rotatory 
nystagmus). This abnormality shows the importance of the nodulus in the normal inhibitory 
control over the vestibular velocity-storage mechanism in the brainstem. This mechanism 
perseverates vestibular responses beyond what the SCC sense when the head rotates at a 
constant speed. Lesions of the nodulus preclude inhibition of velocity-storage and, in extreme 
cases, leads to periodic alternating nystagmus, a classic sign of cerebellar disease. 
Central positional nystagmus 
Lastly, positional nystagmus is a cardinal sign of cerebellar disorder (especially implicating 
nodulus/uvula dysfunction). The two major types are 1) downbeat nystagmus provoked by 
placing the patient in a supine, head-hanging position, and 2) apogeotropic, direction-changing 
horizontal positional nystagmus (always beating skyward regardless of which ear is 
groundward).  Both  types have characteristics that differentiate them from the usual peripheral 
causes of positional nystagmus, posterior or lateral canal benign paroxysmal positional vertigo 
[206].  
 
Quantitative methodology for evaluating eye movements in patients with suspected cerebellar 
dysfunction 
Quantitative recordings are essential in neurology since they provide clinicians and researchers 
a simplified, reliable and objective physiological biomarker complementary to the vagaries of 
historical and examination subjectivity [8]. A detailed description of the methodology and 
advantages and disadvantatges of various types of eye movement recoding techniques can be 
found in tappendix B of [7]. The earliest DC electro-oculography systems, though non-invasive, 
inexpensive and fairly accurate in horizontal range up to ±40 degrees are prone to electrical, 




































































field search-coil technique, in which subjects sit in a weak magnetic field and wear a silastic 
scleral annulus in which a wire is embedded, has been the gold standard for reliability, 
reproducibility, and versatility for assessing eye movements. Magnetic search coils are sensitive 
to minute changes of arc with a wide linear range (±180) in the horizontal and vertical and 
torsional rotations when eyes are open or closed. However, this technique has never been used 
in a routine laboratory setting because the scleral annulus and wire are uncomfortable and not 
tolerated by all subjects. There also is a small risk for corneal abrasions. In the last decade, there 
has been marked improvement in video recording techniques with higher framerate and high-
resolution. They are now in a portable, compact set of goggles, easily applied even at the 
bedside, and well tolerated by almost all patients. Their drawback is possible artifacts, primarily 
related to the position of the lids or slippage of the goggles on the head, which may make 
measures of eye velocity artificially high. An additional requirement, now, is the signal 
digitization for secondary processing requires increasing computation power for increasingly 
algorithmic and automated analysis. As for all eye movement recordings, patient alertness and 
cooperation are required. Despite these limitations the VOG goggles provide relatively accurate 
measures for saccades and vestibular movements and, hence, much needed quantitative data 
[197]. Finally, we emphasize that the careful study of eye movements and vestibular responses 




Clearly, all authors agreed that standard electrophysiological measures are useful to 
demonstrate and, to a certain extent, quantify extracerebellar involvement in ataxias in daily 
practise. Many ataxias have accompanying polyneuropathy, spinal cord and brain stem 
involvement along with pyramidal tracts [11, 12, 21]. Although less common, epilepsy is also 




































































and motor evoked potentials and electroencephalography should be performed as part of the 
diagnostic work-up in patients with unexplained ataxia. Some findings are highly characteristic. 
For example, sensory axonal polyneuropathy is a typical finding in Friedreich’s ataxia, and 
motor evoked potentials (MEP) show increased central motor conduction times in 
spinocerebellar ataxia type 1 (SCA1) [15, 26]. The presence of significant polyneuropathy and 
spinal cord involvement, on the other hand, makes the diagnosis of spinocerebellar ataxia type 
6 (SCA6) or the cerebellar type of multisystem atrophy (MSA-C) very unlikely [22]. None of 
the electrophysiological findings, however, are specific to only one type of ataxia. There are 
ataxias with similar phenotypes, e.g. ataxia with vitamin E deficiency (AVED) resembles 
FRDA [31], on one hand, and different phenotypes of the same type of ataxia on the other hand. 
Finally, many ataxias are accompanied by polyneuropathy and spinal cord involvement at least 
to some extent. That is, abnormalities found in standard electrophysiological testing may often 
be unspecific. Overall, compared to nerve conduction studies and sensory and motor evoked 
potentials EEG may only play a secondary role. Whereas EEG may play an adjunctive role in 
a subset of ataxias which can present with epilepsy (e.g. SCA10, episodic ataxias), for the most 
part EEG findings are nonspecific in ataxias [64, 70]. In contrast, rigorous and standardized 
clinical assessment of saccades and the vestibuloocular reflex, coupled with quantitative 
recordings using infrared goggles or other recording devices may be sensitive and specific to 
cerebellar dysfunction in ataxias [8]. 
All electrophysiological measures, however, are easily available and inexpensive. The authors 
recommend performing electrophysiological assessments including EEG to get a most 
complete picture of the patients’ phenotype. Together with the family history, the clinical signs 
and brain MRI findings provide clues to ataxic subtype and, consequently, inform further 
genetic testing. On the other hand, when results are unclear with genetic panels or whole exome 
sequencing (such as with variants of unknown significance or mutations not deemed 




































































phenotype matches with probable abnormal genetic findings. Yet, for many types of ataxias 
comprehensive studies of electrophysiological measures are missing. Up to now, the majority 
of studies have been performed only in patients with SCA1, 2, 3 and 6. The authors agree that 
future studies describing the phenotype of e.g. newly discovered ataxia-genes should include a 
full standard electrophysiological assessment. Finally, review of the literature shows that nerve 
conduction studies and MEPs can be abnormal in the presymptomatic state of SCAs [25, 38]. 
Thus electrophysiological measures may be helpful to define the onset of the disease and, 
therefore at which time future treatments should start. The authors agree that future studies are 
warranted to investigate whether these electrophysiological measures are sensitive enough to 
show small changes, and can be used as biomarkers in clinical trials. 
As yet there is lack of a singular holistic electrophysiological measure that addresses all 
functions of the cerebellum. All authors agree that it is worthwhile to explore the usefulness of 
cerebellar brain inhibition (CBI) in future studies. CBI is a measure of cerebellar-motor cortex 
(M1) connectivity which allows to indirectly infer the state of cerebellar excitability [49]. CBI 
may be of particular use in early stages of the disease where it is frequently difficult to decide 
whether or not there is involvement of the cerebellum. CBI may also provide additional 
knowledge on the pathophysiology of ataxias, i.e. to localize the anatomical origin of ataxias 
(efferent vs. afferent pathways). Findings should also be different in ataxias affecting primarily 
the cerebellar cortex or the nuclei (at least in the beginning of the disease when little secondary 
changes have been taken place). CBI, however, is based on a paired-pulse TMS paradigm which 
needs not only two coils and magnetic stimulators, but more significant, operator expertise and 
patient cooperation. Future studies are needed to investigate the feasibility and usefulness of 
CBI as part of the routine diagnostic work-up of ataxias. 
The authors agree that quantitative assessments of the leading cerebellar signs – that is 
dysarthria, ataxia of stance and gait and foremost disordered eye movements - are of limited 




































































assessments usually do not provide significantly more information compared to a thorough 
clinical examination. For example, the ability of most quantitative measures to differentiate 
between different causes of balance and gait problems is limited. There is, e.g. no single 
parameter which allows the unequivocal conclusion of a cerebellar deficit. Recording of eye 
movement is an exception, but here, as explained in detail in this article, a comprehensive 
clinical examination does not fall short. A detailed examination of eye movements can be very 
helpful to decide whether or not there is cerebellar involvement and/or extracerebellar signs.  
There is increasing need in the field of ataxias for sensitive biomarkers, in particular to monitor 
very early stages of disease. An increasing number of treatment trials are in the pipeline. These 
trials include both drug and rehabilitation interventions, the latter including physiotherapy and 
speech therapy. In the interest in satisfying the Food and Drug Administration’s (USA) mandate 
that drug trials employ meaningful outcome measures, metrics that measure vision, talking and 
walking are increasingly important. Here clinical measures lack sensitivities despite the 
development of validated clinical ataxia scores [104]. Quantitative measures of ataxia as yet 
largely depend on expensive and advanced equipment, e.g. force plates and multiple camera 
systems. Currently systems on the basis of body-worn sensor technology are developed to 
quantify gait and balance performance in daily life. More portable measures of eye movements 
exist and these may serve as a proxy for cerebellar dysfunction in gait and posture. For example, 
quantifying the amplitude (gain) of the vestibulo-ocular reflex can be correlated with other 
measures of progression in patients with SCA6 [200]. All of these systems will allow 
assessment of treatment responses during daily life, for instance quantifying the improvement 
in gait variability and body sway at home or walking outside. 
The authors note that ataxias are also frequently accompanied by dysphagia [207] and sleeping 
disorders. Polysomnography and clinical and instrumental swallowing diagnostics are helpful 




































































In summary, the authors recommend performing standard electrophysiological measures 
including nerve conduction studies, sensory and motor evoked potentials and EEG in all 
patients with newly diagnosed ataxias. Whether or not these measures are useful biomarkers 
need to be established in future studies. Future studies are also needed to explore whether 
cerebellar brain inhibition (CBI), which addresses cerebellar function more directly, is a useful 
additional TMS measure. Quantitative measures of ataxia and eye movements are likely useful 












































































Table 1: Peripheral nerve affection in hereditary ataxias 
Predominant sensory neuropathy 
 Friedreich’s ataxia: Axonal sensory neuropathy 
 Sensory ataxic neuropathy, dysarthria and ophthalmoplegia (SANDO) with POLG 
mutations 
 Ataxia with vitamin E deficiency (AVED) 
 Abetalipoproteinemia 
 Spinocerebellar ataxia type 2 
Sensory-motor neuropathy 
 Autosomal recessive spastic ataxia type Charlevoix-Saguenay (ARSACS) 
 Ataxia telangiectasia 
 Ataxia with oculomotor apraxia type 1 (AOA1) 
 Ataxia with oculomotor apraxia type 1 (AOA2) 
 GM2 gangliosidosis Tay-Sachs 
 Spinocerebellar ataxia type 1 
 Spinocerebellar ataxia type 3 








































































Table 2. Cerebellar ataxias and their most relevant EEG counterparts. 
Cerebellar ataxia EEG findings Authors/Reference 
Friedreich´s ataxia Abnormal slow or irregular background 
rhythms 
Remillard et al. [53] 
ARSACS Generalized spikes and waves Anheim et al. [54] 
Ramsay-Hunt syndrome Cortical spikes or spike-wave forms van Egmond et al. [55] 
NCLS Slow spike waves and photoparoxysmal 
responses 
Canafoglia et al. [57]  
Lafora disease Slowing of the background activity & 
paroxysms of generalized irregular spike-
wave discharges 
Jansen et al. [58] 
ULD Slow and disorganized background rhythms 
and spikes waves 
Gargouri-Berrechid  et al. 
[59] 
GLUT-1 deficiency Pre-postprandial changes of the background 
activity 
Ito et al. [60]  
SCA type 1 and 2 non-specific Rakowicz et al. [62]  
SCA type 17 non-specific Belluzzo et al. [63]  
SCA type 10 Unifocal or bilateral epileptiform discharges Grewal et al. [65]  
SCA type 10 No unequivocal epileptiform activity found Teive et al. [67]  
DRPLA Bursts of frontal and central slowing, with 
diffuse spike-wave discharges 
Licht et al. [68]  
EA Intermittent delta activity and low 
amplitude spikes 
Bogaert & Szliwowski. [72]  
Mitochondrial ataxias Photomyoclonic response Träff et al. [73]  
ARSACS= autosomal recessive spastic ataxia of Charlevoix-Saguenay; NCLs= neuronal 
lipofuscinoses; ULD= Unverricht-Lundborg disease; GLUT1=glucose transporter type 1; 







































































Table 3: Speech assessments by domain 
Assessment domain Examples Description Administration 
time / Expertise 
required 
Impairment 








lips, tongue, palate and 
larynx.  




PATA rate in the 
SCAFI [95] 
Patient repeats “PATA” 
as quickly and 
distinctly as possible 
for 10 seconds. Rate 
regularity and speed 











Perceptual analysis of 
speech subsystems 
including resonance, 
voice quality, rate, 
intonation, loudness 
and intelligibility  








of timing, control 
and quality 
aspects of speech 
Analysis of speech 
signal using software 
(e.g., Praat) examining 
spectral/cepstral 
properties of speech 
Rapid | some 
expertise needed in 
administration and 
interpretation  







social impact of 
dysarthria 
15-20 mins | Survey 
completed by 
patients 




































































Table 4 Overview of studies examining cerebellar ataxic gait in different conditions.  




Condition Main results  
Palliyath et 
al.  [113] 
10: OPCA, 
CCA 
Gait Reduced step length, impairments in 
multi-joint coordination, increased 
variability of several gait measures.  
Morton and 





Gait Balance deficits are more closely 
related to cerebellar gait ataxia than 
leg-placement deficits 
Stolze et al. 
[116] 
12: CD with 
various causes 
Gait Reduced cadence, increased balance 
related variables; tandem gait 
paradigm accentuates gait ataxia 





Gait Temporal variability in intra-limb 






Gait Irregular alternating joint 
behavior, increased variability of 





Gait EMG reveals muscle high activity 
during periods when these muscles 
were not active in normal walking. 





Gait Alterations in the speed dependency 
of stride time and stride length 
variability, whereas base width 
variability remained unaffected. 
Ilg et al.  
[143] 







Spatio-temporal gait variability 
measures are further increased with 
the complexity of the cognitive task 
in dual task paradigms for gait and 
tandem gait  
Schniepp et 
al.  [140] 
58: 
SAOA,SCA1 
Gait, Falls Severity of ataxia, dynamic stability, 
and occurrence of falls interrelated in 






































































Severity of ataxia related to 
instability during fast walking. (b) 
Fall frequency associated with 
instability during slow walking. 
Serrao et 
al.  [122] 
12:  SAOA, 
SCA1, SCA2, 
Gait  At the 4-year follow-up, significant 
decrease in step length and in the hip, 
knee, ankle joint RoM values, 
increase in trunk rotation, and step 
length variability. 
Rochester 
et al.  [127] 
6: SCA 6, 
preclinical  
Gait   Increased variability of step width 
and step time in pre-clinical subjects  









Preclinical SCA Mutation carriers 
without any clinical gait sign show 
significant increase in spatio-









Similarities between oculomotor 
deficits during visual fixation task 
and when walking  
Crowdy et 
al. [145] 
2: ADCA Visually 
guided 
walking 
Foot placement accuracy could be 
improved by prior practice in making 
saccadic eye movements towards the 
targets. 
Timmann 
et al.  [146] 
8: 
ADCA,IDCA, 
EA-type 2  
Gait 
initiation 
Modification of postural adjustments  
Conte et al. 





Compensatory strategies during gait 
termination, e.g. increasing their step 
width and number of steps 





Turning Compensatory strategies: enlarge the 
base of support, shorten step length, 
increase number of steps, and use the 
"multi-step" rather than the "spin-









































































stepping on  
inclined 
surfaces 
Abnormal relative movement of hip, 
knee, and ankle joints, decomposition 







Dynamic abnormalities associated 
with leg hypermetria is context-
specific, voluntary compensatory 
strategies 






 Cerebellum is important for 
regulation of the amplitude of 









Specific impairments at making 
predictive changes in temporal 
aspects of intra-limb coordination  
Ilg et al.  
[153]   






Specific abnormalities in temporal 
aspects of intra-limb coordination for 
leg placement and adaptive 
locomotion 






Gait rehab Intensive coordination training 
improves gait in terms of velocity, 
lateral sway and variability of 
intralimb coordination pattern  




Gait rehab Physiotherapy in combination with 
occupational therapy improves gait 
speed and fall frequency  





Gait rehab Video-gamed based coordination 
training in children improves 
velocity, step length variability, 
dynamic balance 
: number of patients; IDCA: idiopathic cerebellar ataxia; CD: cerebellar disease; ADCA: 
autosomal dominant cerebellar ataxia;  SCA 6: spinocerebellar ataxia type 6;  SCA 2: 
spinocerebellar ataxia type 2;  SANDO: sensory ataxic neuropathy with dysarthria and 
ophthalmoparesis caused by mutations in the polymerase gamma gene (POLG); FRDA: 
Friedreich’s ataxia;   PVS: posterior vermal split; SAOA: sporadic adult onset ataxia of 
unknown etiology; OPCA: olivopontocerebellar atrophy, CCA: cerebellar cortical atrophy; 
LCCA: late cerebellar cortical atrophy; EA-type 2: episodic ataxia type 2; CAI: cerebellar artery 
infarct;  AOA2: ataxia with oculomotor ataxia type 2; arCA : autosomal-recessive ataxia. RoM: 






































































Table 5.  Summary of effects of ataxia on postural control  
Authors/Reference : Patients’ 
description  
Type of postural 
task 
Main results 
Sway in Stance 
Diener et al. [159] 41:  vermis,  
Friedreich’s,  
ant lobe,  
diffuse, 
hemispheres  
25 sec, normal 
stance EO and EC, 
force plate 
86% of subjects increased 
sway path or area, visual 
stabilization in Friedreich’s 
and ant lobe, 0.1-1 Hz AP 
sway in Friedreich’s and 2-4Hz 
in Ant lobe 
Van de Warrenburg 
et al. [161]   
11: SCA 20 sec, normal 
stance, EO and EC 
on foam and firm 
with digital angular 
velocity on low 
back 
Greater trunk angle change 
and angular velocity esp. pitch 
plane oscillations 1.4-2.5 Hz, 
larger increase sway with EC 
and foam 







Increased sway in vestibular 
conditions (esp. EC on 
unstable surface) 
Schoch et al. [162] 16: surgical 
benign 
tumors 
15 sec, sitting and 
standing EO and 
EC on firm and 
foam; ultrasound 
markers on trunk 
Largest sway when both vision 
and surface compromised in 
standing, esp. when fastigial 
nuclei and interposed nuclei 
involved 
Bunn et al. [163] 17: SCA6 40 sec, EO, various 
foot width, force 
plate 
Global instability and ankle 
instability in role, especially 
narrow stance 
Matsushima et al. 
[158] 
51: SCA or 
MSA-C 
30 sec, feet apart 
and together EO 
and EC, 
accelerometers 
Large horizontal acceleration 
vector magnitude in all 
conditions; feet apart EO 





































































Jacobi et al. [164]  20: SCA6,  
ADCA-III,  
cerebellitis 
20 sec, static and 
dynamic 
posturography  
Dual tasks reduced sway path 
more than normal in complex 
conditions; increased risk of 
falls 
Anticipatory Postural Adjustments 




Rise to tip toes fast 
to audio trigger on 
force-plate 
APA latencies long, variable, 











Normal APA and adaptation, 
smaller/slower steps, inability 
to scale APA based on 
anticipation 
Asaka and Wang, 
[167] 
9: SCA Sudden release of 
load to arms while 
standing 
Normal APA pattern but more 
co-contraction and background 
muscle activity 
Bruttini et al. [168] 13: sporadic, 
dominant, 
recessive  
Brisk index finger 
flexion while 
sitting 
Same shoulder/elbow muscles 
active but delayed latencies 
Postural Responses 
Diener et al. [169]  41: 
degenerative 
Fast, surface 
rotations toes up 
Normal latencies of all EMG 
responses, but an increase in 
duration and amplitude of the 
long latency response 







Loss of predictive scaling to 
amplitudes but normal reactive 
scaling to velocities, increased 
amplitude with compensatory 




12:  ADCA,  
IDCA, EA-
type 2, 
Serial and random 
surface translation 
amplitudes 
Can predict amplitudes based 
on prior experience but cannot 











































































toes up rotations 
Normal adaptation of postural 
synergies to changing stimulus 
types of surface displacement 
Bakker et al. [172] 9: SCA Surface rotations 
random directions 
Hypermetric response (esp. 
backward and lateral), locking 
knees 
Paquette et al. [179]  8: chronic, 
degenerative 
Very slow (1 deg/s) 
surface toes up 
rotation 
More falls, fast backward trunk 
displacements 
: number of patients; IDCA: idiopathic cerebellar ataxia; ADCA: autosomal dominant 











































































Table 6. Select clinicopathological anatomical correlates 
Anatomical location  EOM physiologic function  Prototypical pathology  
EOM exam and relevant 
findings  
Flocculus & Paraflocculus 
(Tonsil) 
• Inhibition of vestibular nuclei, 
especially anterior canal pathways 
• Pursuit 
• Facilitate gaze holding  
• r-VOR direction and amplitude, 
cancellation of the VOR when 
tracking a target moving with the 
head 
• SCA6 
• Arnold Chiari malformation 
(local tonsil and brainstem 
compression) 
• Primary position fixation 
(downbeat nystagmus) 
• Gaze-holding (gaze-evoked 
nystagmus) 
• VOR (HIT) amplitude (early 
high, late low); Commonly cross-
coupling (abnormal slow phase up 
with horizontal head rotation, and 
VOR cancellation is impaired 
with unwanted nystagmus 
• Smooth pursuit (choppy) 
Nodulus & Ventral Uvula • Control of velocity-storage 
mechanism in brainstem, 
determines duration of vestibular 
responses 
• Mediation of effects of gravity 
on VOR including tilt suppression 
of post rotatory VOR 
• Medulloblastoma • Tilt-suppression of post rotatory 
nystagmus (impaired) PAN 
(periodic alternating nystagmus) 
• Screen for supine nystagmus 























































• Observe for OTR and SVV 
abnormality  
Oculomotor Vermis & Paravermis • Saccade accuracy (inhibits FOR) • SCA6 (early vermis, late FOR) • Asking the subject to rapidly 
fixate between fixed objects, 
looking for dysmetria (hypometria 
(vermis) and hypermetria (FOR)) 
Fastigial Nucleus (FOR) • Saccade accuracy (acts as a 
brake to stop saccades on target) 
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